Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-13-047879
Filing Date
2013-08-27
Accepted
2013-08-26 18:15:27
Documents
6
Period of Report
2013-10-15
Effectiveness Date
2013-08-27

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A v353799_def14a.htm DEF 14A 321422
2 GRAPHIC tlogo.jpg GRAPHIC 7302
3 GRAPHIC tmail.jpg GRAPHIC 1041
4 GRAPHIC tfax.jpg GRAPHIC 1118
5 GRAPHIC tinternet.jpg GRAPHIC 1321
6 GRAPHIC tphone.jpg GRAPHIC 1441
  Complete submission text file 0001144204-13-047879.txt   340319
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEF 14A | Act: 34 | File No.: 000-17263 | Film No.: 131061080
SIC: 2836 Biological Products, (No Diagnostic Substances)